Ischemic Optic Neuropathy

Ischemic Optic Neuropathy happens when the blood supply to your optic nerve gets blocked. This blockage can be caused by several things, like inflammation or hardening of the arteries. It usually affects the front part of the optic nerve, causing sudden, painless vision loss in one eye. Sometimes, the back part of the nerve is affected instead, but the optic nerve looks normal in that case.

Condition

What people with Ischemic Optic Neuropathy report

Every report comes from a Lived member, sent anonymously.

Have you tried Prednisone for Ischemic Optic Neuropathy?

NameHow it went

About Ischemic Optic Neuropathy

What It Is

Ischemic optic neuropathy (ION) is damage to the optic nerve caused by a lack of blood flow. The optic nerve carries visual signals from the eye to the brain, so when part of it is starved of oxygen, the vision it serves is lost. It is sometimes described as a stroke of the optic nerve. The typical experience is sudden, painless loss of vision in one eye, often noticed on waking. Some people lose part of their field of view, frequently the upper or lower half, while others notice general dimming, blurring or duller colors. ION mostly affects people over 50, and the vision lost is often permanent. Doctors separate ION by cause and location. The most common form, nonarteritic anterior ischemic optic neuropathy (NAION), happens without any inflammation of the arteries. The less common arteritic form is caused by giant cell arteritis, an inflammation of medium and large arteries in older adults, and usually causes more severe vision loss. Posterior ION affects the nerve farther behind the eye and is rarer.

Causes & Risk Factors

NAION usually results from several factors that together interrupt blood flow at the front of the optic nerve, rather than from one identifiable cause. The strongest anatomical risk factor is a small, crowded optic disc (the spot where the nerve leaves the eye), which leaves little room when the nerve swells. Conditions that affect small blood vessels also raise risk, including diabetes, high blood pressure, high cholesterol, smoking and obstructive sleep apnea. Because vision loss is so often noticed on waking, researchers suspect that blood pressure dipping during sleep may play a part. Certain medicines have been linked to NAION. Erectile dysfunction drugs such as sildenafil (Viagra) carry a label warning, although a causal link has not been proven. Large observational studies have also associated semaglutide (Ozempic, Wegovy), a diabetes and weight-loss medicine, with a higher rate of NAION. European regulators now list it as a very rare possible side effect, while the US label does not, and studies disagree on how strong the link is. Anyone who has had NAION should review these medicines with their doctor. The arteritic form is caused by giant cell arteritis, which typically affects people around 70 and older. Posterior ION can follow severe blood loss or a sharp drop in blood pressure, including low blood pressure during surgery.

How It's Diagnosed

An eye specialist, often a neuro-ophthalmologist (an eye doctor who specializes in the optic nerve and its connections to the brain), confirms the diagnosis by examining the back of the eye after dilating the pupils. In anterior ION the optic disc looks swollen, sometimes with small hemorrhages around it. Tests of the visual field map which areas of vision are missing, and optical coherence tomography (OCT), a quick scan using light, measures swelling and later thinning of the nerve fibers. The specialist also checks how the pupils respond to light, since a damaged optic nerve changes that reflex. The most urgent step is ruling out giant cell arteritis. Blood tests for inflammation, the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are usually markedly raised in the arteritic form and normal in NAION. If giant cell arteritis is suspected, a small sample of the temple artery (a temporal artery biopsy) is taken to confirm it, ideally within two weeks of starting treatment. Posterior ION is harder to diagnose because the optic disc looks normal at first. Magnetic resonance imaging (MRI) may be used to exclude other causes such as inflammation of the optic nerve or a growth pressing on it. People with NAION may also be checked for diabetes, high cholesterol and, when snoring or daytime sleepiness suggest it, sleep apnea.

Treatment Options

Treatment depends on which form is present. For the arteritic form, high-dose corticosteroids (anti-inflammatory steroid medicines such as prednisone) are started immediately, often before the biopsy, and sometimes given intravenously at first. They rarely restore vision already lost, but they greatly reduce the risk of losing sight in the other eye. Steroids are then tapered slowly over months. Tocilizumab (Actemra), an injected medicine that blocks an inflammatory signal, is approved for giant cell arteritis and is often added to reduce relapses and the total steroid dose. Long steroid courses carry real side effects, so the care team monitors them and aims for the lowest dose that keeps the arteritis quiet. For NAION, no treatment has been proven to restore vision. Steroids are not generally recommended without arteritis, and a large trial found that surgery to relieve pressure on the optic nerve did not help and could make vision worse. Care instead focuses on protecting the other eye: controlling diabetes, cholesterol and blood pressure, treating sleep apnea, stopping smoking and reviewing medicines. Some doctors adjust when blood pressure medicines are taken to avoid very low pressure overnight. Whatever the cause, low-vision rehabilitation can help people make the most of the vision they have, using magnifiers, high-contrast lighting, large print and speech or magnification features on phones and computers.

What to Expect

Vision in NAION usually settles over the first few months and then stays fairly stable. A meaningful share of people regain some vision on their own, but most keep a lasting gap in their field of view or reduced sharpness. The larger concern is the other eye: about 15% of people with NAION develop it in the second eye within about five years. Vision loss from the arteritic form tends to be more severe, and ongoing treatment of giant cell arteritis, usually with a rheumatologist, often continues for many months. Losing vision in one eye affects depth perception and awareness of objects on that side, which can make steps, curbs and pouring liquids harder at first. Most people adapt over time by turning their head more and relying on the better eye. Whether driving remains possible depends on the remaining vision in both eyes and on local licensing rules. Follow-up visits track how the nerve settles, and longer-term care focuses on managing blood vessel risk factors. If surgery is ever planned, it helps to tell the surgeon and anesthesiologist about past ION.

When to Seek Help

After a diagnosis of ION, keep your follow-up visits and report any new change in vision in either eye, such as a gradual blur or a blind spot that has not gone away. Contact a doctor the same day if you are over 50 and develop a new headache, tenderness over the temples or pain in the jaw when chewing, because these can signal giant cell arteritis before it damages sight. Sudden loss or dimming of vision in either eye is an emergency, including brief episodes that clear on their own. Seek emergency care right away, since prompt assessment can protect the other eye and rule out a stroke.

Questions to Ask Your Doctor

  1. 1.Which form of ischemic optic neuropathy do I have, and how sure are we that giant cell arteritis has been ruled out?
  2. 2.How much of my vision is likely to return, and when will we know it has stabilized?
  3. 3.What can I do to lower the risk of this happening in my other eye?
  4. 4.Should any of my current medicines, including blood pressure, erectile dysfunction or weight-loss medicines such as semaglutide, be changed?
  5. 5.Would low-vision services help me, and is it safe for me to drive?

Last reviewed • Oct 2026

Educational content, not medical advice.